It is common for sponsors to switch digital platforms between clinical trial phases, but sponsors can achieve much by using ...

Two years after the FDA placed partial clinical hold, Avidity can resume research of del-desiran as a treatment for myotonic ...

The roadmap suggests those with the greatest clinical need will get priority access, according to the NHS national medical ...

Recordati has reached an agreement with Sanofi for acquiring the worldwide rights to Enjaymo, the only approved treatment ...

Teva Pharmaceuticals International and mAbxience have entered into a worldwide licencing agreement to develop an anti ...

Bristol Myers Squibb (BMS) has received approval from the US Food and Drug Administration (FDA) for Opdivo to treat adults ...

National Resilience’s subsidiary Resilience Government Services has received around $17.5m in funding for expanding critical ...

At ELRIG 2024, Dr. Maria Duca described how her lab’s rational design approach bypasses lengthy screening protocols.